Mitotic Perturbation Is a Key Mechanism of Action of Decitabine in Myeloid Tumor Treatment
Tomohiro Yabushita(The University of Tokyo), Susumu Goyama(Molecular Oncology (United States)), Yosuke Tanaka, Makoto Nakanishi(The Cancer Institute Hospital), Tomoyoshi Soga(Keio University), Toshio Kitamura(National Agriculture and Food Research Organization), Shuhei Asada(The University of Tokyo), Yasuhito Nannya(Kyoto University), Daiju Kitagawa(National Institute of Genetics), Yutaka Enomoto(The University of Tokyo), Atsuya Nishiyama(The University of Tokyo), Naru Sato(The University of Tokyo), Keita Yamamoto(The University of Tokyo), Hitoshi Sato(The University of Tokyo), Keiko Katoh(Keio University), Takamasa Ishikawa(Keio University), Kaori Saitoh(Yamagata University), Takumi Chinen(National Institute of Genetics)
Cited by 3
Related Papers
MassBank: a public repository for sharing mass spectral data for life sciences
|Journal of Mass Spectrometry|2010|2.6k
Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer
|Nature Medicine|2019|1.5k
Navigating the DNA methylation landscape of cancer
|Trends in Genetics|2021|1k